PARSHALL B LYNNE (CIK 1073385) reported 13 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-01). Recent activity: Sell CYTK (5,000 shares), Sell IONS (4,466 shares), Sell IONS (534 shares), Sell CYTK (5,000 shares), Sell IONS (5,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-01 | CYTOKINETICS INC (CYTK) | Director | Sell | 5,000 | $370,400 |
| 2026-04-17 | IONIS PHARMACEUTICALS INC (IONS) | Director | Sell | 4,466 | $340,265 |
| 2026-04-17 | IONIS PHARMACEUTICALS INC (IONS) | Director | Sell | 534 | $41,102 |
| 2026-03-02 | CYTOKINETICS INC (CYTK) | Director | Sell | 5,000 | $306,050 |
| 2026-02-13 | IONIS PHARMACEUTICALS INC (IONS) | Director | Sell | 5,000 | $413,600 |
| 2025-11-19 | CYTOKINETICS INC (CYTK) | Director | Sell | 5,000 | $323,650 |
| 2025-10-16 | IONIS PHARMACEUTICALS INC (IONS) | Director | Sell | 5,000 | $358,700 |
| 2025-09-04 | IONIS PHARMACEUTICALS INC (IONS) | Director | Sell | 10,750 | $542,015 |
| 2025-09-04 | IONIS PHARMACEUTICALS INC (IONS) | Director | Sell | 9,250 | $476,282 |
| 2025-08-08 | IONIS PHARMACEUTICALS INC (IONS) | Director | Sell | 4,600 | $192,602 |
| 2025-08-08 | IONIS PHARMACEUTICALS INC (IONS) | Director | Sell | 400 | $17,052 |
| 2025-07-17 | IONIS PHARMACEUTICALS INC (IONS) | Director | Buy | 4,079 | $0 |
| 2025-05-15 | CYTOKINETICS INC (CYTK) | Director | Buy | 7,333 | $0 |
Source: SEC Form 4 filings · as of 2026-06-01